Europe: Reflector - Pharmaceutical Executive


Europe: Reflector

Sweden takes the reins

August 25, 2009

The presence of a high-flying Obama administration insider at the upcoming Swedish life sciences summit is just one indication of the seriousness with which the country taking its EU presidency.

Belgium's statin stalemate

August 11, 2009

Reflector reports on how Belgium's best intentions have backfired on its generics manufacturers.

The EC antitrust report results are in. Time to pop open the champagne?

July 28, 2009

The climax of the antitrust investigation instigated with all guns blazing by EC commissioner Neelie Kroes last year has been a whimper, not a bang. Reflector reports.

Big Pharma isn't dead, but long live small pharma!

July 14, 2009

As the major companies grapple with various crises from patent expirations to regulatory clampdowns, Reflector looks at how small pharma is coming into its own.

Big Pharma: muscling further into Brussels?

April 28, 2009

News of the potential Solvay sale has sent the company's stock soaring, but is it good news for Belgium? Reflector reports.

Pharma on thin ice

April 14, 2009

Reflector points to a number of recent alarm signals that have seen European pharma move further towards dangerous territory.

An uphill struggle for European Pharma

March 31, 2009

Reflector ponders recent events in the battle against counterfeit drugs.

Does Brussels need a wake-up call on medicines?

March 17, 2009

Reflector ponders the growing gap between the US and Europe's vision for the future of drug marketing.

EU and industry in shock agreement

February 24, 2009

Reflector welcomes the signs of EU agreement on encouraging the development of rare disease treatments.


Click here